Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 12854 | 877 | 45.3 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 602 | 3 | OSTEOPONTIN//AMELOGENIN//TOOTH DEVELOPMENT | 14479 |
| 3692 | 2 | SPARC//OSTEONECTIN//JWA | 1121 |
| 12854 | 1 | SPARC//OSTEONECTIN//BM 40 | 877 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | SPARC | authKW | 4808982 | 27% | 58% | 240 |
| 2 | OSTEONECTIN | authKW | 1547775 | 11% | 47% | 95 |
| 3 | BM 40 | authKW | 598509 | 2% | 90% | 19 |
| 4 | HEVIN | authKW | 502741 | 2% | 76% | 19 |
| 5 | SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE | authKW | 495608 | 3% | 65% | 22 |
| 6 | TESTICAN | authKW | 334234 | 1% | 80% | 12 |
| 7 | HOPE HEART PROGRAM | address | 326808 | 4% | 28% | 33 |
| 8 | BARBARA JANE LEVY MOL NEUROONCOL | address | 294909 | 1% | 71% | 12 |
| 9 | SPOCK1 | authKW | 256373 | 1% | 82% | 9 |
| 10 | ACIDIC AND RICH IN CYSTEINE | authKW | 243716 | 1% | 100% | 7 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cell Biology | 2233 | 27% | 0% | 235 |
| 2 | Oncology | 2077 | 26% | 0% | 231 |
| 3 | Biochemistry & Molecular Biology | 767 | 27% | 0% | 241 |
| 4 | Pathology | 231 | 5% | 0% | 46 |
| 5 | Developmental Biology | 160 | 3% | 0% | 27 |
| 6 | Endocrinology & Metabolism | 111 | 6% | 0% | 49 |
| 7 | Medicine, Research & Experimental | 98 | 5% | 0% | 45 |
| 8 | Ophthalmology | 52 | 3% | 0% | 24 |
| 9 | Anatomy & Morphology | 43 | 1% | 0% | 10 |
| 10 | Neurosciences | 39 | 7% | 0% | 58 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HOPE HEART PROGRAM | 326808 | 4% | 28% | 33 |
| 2 | BARBARA JANE LEVY MOL NEUROONCOL | 294909 | 1% | 71% | 12 |
| 3 | HERMELIN BRAIN TUMOR | 65030 | 2% | 12% | 16 |
| 4 | GAZES CARDIAC | 59320 | 2% | 11% | 15 |
| 5 | HORMONE ENDOCRINOL | 46421 | 0% | 67% | 2 |
| 6 | 405 ZLF | 34817 | 0% | 100% | 1 |
| 7 | AGR PROGRAM BIOCHEM REGULAT | 34817 | 0% | 100% | 1 |
| 8 | ANTI CANC DRUG CLIN | 34817 | 0% | 100% | 1 |
| 9 | BARBARA JANE LEVY | 34817 | 0% | 100% | 1 |
| 10 | BARBARA JANE LEVY MOL NEURO ONCOL | 34817 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | 5299 | 1% | 3% | 6 |
| 2 | MATRIX BIOLOGY | 3712 | 1% | 1% | 12 |
| 3 | JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY | 1707 | 2% | 0% | 17 |
| 4 | JOURNAL OF CELLULAR BIOCHEMISTRY | 1533 | 2% | 0% | 20 |
| 5 | CONNECTIVE TISSUE RESEARCH | 1243 | 1% | 0% | 8 |
| 6 | CALCIFIED TISSUE INTERNATIONAL | 1199 | 1% | 0% | 13 |
| 7 | COLLAGEN AND RELATED RESEARCH | 989 | 0% | 1% | 3 |
| 8 | NEOPLASIA | 733 | 1% | 0% | 6 |
| 9 | CANCER AND METASTASIS REVIEWS | 706 | 1% | 0% | 5 |
| 10 | DEVELOPMENT GENES AND EVOLUTION | 682 | 1% | 0% | 5 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SPARC | 4808982 | 27% | 58% | 240 | Search SPARC | Search SPARC |
| 2 | OSTEONECTIN | 1547775 | 11% | 47% | 95 | Search OSTEONECTIN | Search OSTEONECTIN |
| 3 | BM 40 | 598509 | 2% | 90% | 19 | Search BM+40 | Search BM+40 |
| 4 | HEVIN | 502741 | 2% | 76% | 19 | Search HEVIN | Search HEVIN |
| 5 | SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE | 495608 | 3% | 65% | 22 | Search SECRETED+PROTEIN+ACIDIC+AND+RICH+IN+CYSTEINE | Search SECRETED+PROTEIN+ACIDIC+AND+RICH+IN+CYSTEINE |
| 6 | TESTICAN | 334234 | 1% | 80% | 12 | Search TESTICAN | Search TESTICAN |
| 7 | SPOCK1 | 256373 | 1% | 82% | 9 | Search SPOCK1 | Search SPOCK1 |
| 8 | ACIDIC AND RICH IN CYSTEINE | 243716 | 1% | 100% | 7 | Search ACIDIC+AND+RICH+IN+CYSTEINE | Search ACIDIC+AND+RICH+IN+CYSTEINE |
| 9 | MATRICELLULAR | 228278 | 2% | 33% | 20 | Search MATRICELLULAR | Search MATRICELLULAR |
| 10 | SPARC OSTEONECTIN BM 40 | 208899 | 1% | 100% | 6 | Search SPARC+OSTEONECTIN+BM+40 | Search SPARC+OSTEONECTIN+BM+40 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | CHLENSKI, A , COHN, SL , (2010) MODULATION OF MATRIX REMODELING BY SPARC IN NEOPLASTIC PROGRESSION.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. VOL. 21. ISSUE 1. P. 55-65 | 126 | 90% | 67 |
| 2 | NAGARAJU, GP , DONTULA, R , BASSEL, EF , LAKKA, SS , (2014) MOLECULAR MECHANISMS UNDERLYING THE DIVERGENT ROLES OF SPARC IN HUMAN CARCINOGENESIS.CARCINOGENESIS. VOL. 35. ISSUE 5. P. 967 -U69 | 96 | 82% | 28 |
| 3 | PODHAJCER, OL , BENEDETTI, LG , GIROTTI, MR , PRADA, F , SALVATIERRA, E , LLERA, AS , (2008) THE ROLE OF THE MATRICELLULAR PROTEIN SPARC IN THE DYNAMIC INTERACTION BETWEEN THE TUMOR AND THE HOST.CANCER AND METASTASIS REVIEWS. VOL. 27. ISSUE 4. P. 691 -705 | 132 | 70% | 83 |
| 4 | PODHAJCER, OL , BENEDETTI, L , GIROTTI, MR , PRADA, F , SALVATIERRA, E , LLERA, AS , (2008) THE ROLE OF THE MATRICELLULAR PROTEIN SPARC IN THE DYNAMIC INTERACTION BETWEEN THE TUMOR AND THE HOST.CANCER AND METASTASIS REVIEWS. VOL. 27. ISSUE 3. P. 523 -537 | 132 | 70% | 43 |
| 5 | ARNOLD, SA , BREKKEN, RA , (2009) SPARC: A MATRICELLULAR REGULATOR OF TUMORIGENESIS.JOURNAL OF CELL COMMUNICATION AND SIGNALING. VOL. 3. ISSUE 3-4. P. 255-273 | 133 | 63% | 65 |
| 6 | NEUZILLET, C , TIJERAS-RABALLAND, A , CROS, J , FAIVRE, S , HAMMEL, P , RAYMOND, E , (2013) STROMAL EXPRESSION OF SPARC IN PANCREATIC ADENOCARCINOMA.CANCER AND METASTASIS REVIEWS. VOL. 32. ISSUE 3-4. P. 585-602 | 88 | 78% | 41 |
| 7 | RIBEIRO, N , SOUSA, SR , BREKKEN, RA , MONTEIRO, FJ , (2014) ROLE OF SPARC IN BONE REMODELING AND CANCER-RELATED BONE METASTASIS.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 115. ISSUE 1. P. 17-26 | 68 | 84% | 10 |
| 8 | TAI, IT , TANG, MJ , (2008) SPARC IN CANCER BIOLOGY: ITS ROLE IN CANCER PROGRESSION AND POTENTIAL FOR THERAPY.DRUG RESISTANCE UPDATES. VOL. 11. ISSUE 6. P. 231 -246 | 90 | 66% | 91 |
| 9 | CLARK, CJ , SAGE, EH , (2008) A PROTOTYPIC MATRICELLULAR PROTEIN IN THE TUMOR.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 104. ISSUE 3. P. 721-732 | 75 | 70% | 72 |
| 10 | NAGARAJU, GPC , SHARMA, D , (2011) ANTI-CANCER ROLE OF SPARC, AN INHIBITOR OF ADIPOGENESIS.CANCER TREATMENT REVIEWS. VOL. 37. ISSUE 7. P. 559-566 | 77 | 68% | 21 |
Classes with closest relation at Level 1 |